Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prevalence, Temporal Evolution, and Impact on Survival of Ventricular Conduction Blocks in Patients With Acute Coronary Syndrome and Cardiogenic Shock.
Tolppanen H, Javanainen T, Sans-Rosello J, Parenica J, Nieminen T, Pavlusova M, Masip J, Köber L, Banaszewski M, Sionis A, Spinar J, Harjola VP, Jurkko R, Lassus J; CardShock study investigators and for the GREAT Network. Tolppanen H, et al. Among authors: javanainen t. Am J Cardiol. 2018 Jul 15;122(2):199-205. doi: 10.1016/j.amjcard.2018.04.008. Epub 2018 Apr 20. Am J Cardiol. 2018. PMID: 29778237
Predictive value of the baseline electrocardiogram ST-segment pattern in cardiogenic shock: Results from the CardShock Study.
Javanainen T, Tolppanen H, Lassus J, Nieminen MS, Sionis A, Spinar J, Silva-Cardoso J, Greve Lindholm M, Banaszewski M, Harjola VP, Jurkko R. Javanainen T, et al. Ann Noninvasive Electrocardiol. 2018 Sep;23(5):e12561. doi: 10.1111/anec.12561. Epub 2018 May 30. Ann Noninvasive Electrocardiol. 2018. PMID: 29846022 Free PMC article.
Hypoalbuminemia is a frequent marker of increased mortality in cardiogenic shock.
Jäntti T, Tarvasmäki T, Harjola VP, Parissis J, Pulkki K, Javanainen T, Tolppanen H, Jurkko R, Hongisto M, Kataja A, Sionis A, Silva-Cardoso J, Banaszewski M, Spinar J, Mebazaa A, Lassus J; CardShock investigators. Jäntti T, et al. Among authors: javanainen t. PLoS One. 2019 May 16;14(5):e0217006. doi: 10.1371/journal.pone.0217006. eCollection 2019. PLoS One. 2019. PMID: 31095609 Free PMC article.
Levels of Growth Differentiation Factor 15 and Early Mortality Risk Stratification in Cardiogenic Shock.
Hongisto M, Kataja A, Tarvasmäki T, Holopainen A, Javanainen T, Jurkko R, Jäntti T, Kimmoun A, Levy B, Mebazaa A, Pulkki K, Sionis A, Tolppanen H, Wollert KC, Harjola VP, Lassus J; CardShock investigators. Hongisto M, et al. Among authors: javanainen t. J Card Fail. 2019 Nov;25(11):894-901. doi: 10.1016/j.cardfail.2019.07.003. Epub 2019 Jul 13. J Card Fail. 2019. PMID: 31310811 Clinical Trial.
Acute Heart Failure Management.
Čerlinskaitė K, Javanainen T, Cinotti R, Mebazaa A; Global Research on Acute Conditions Team (GREAT) Network. Čerlinskaitė K, et al. Among authors: javanainen t. Korean Circ J. 2018 Jun;48(6):463-480. doi: 10.4070/kcj.2018.0125. Korean Circ J. 2018. PMID: 29856141 Free PMC article. Review.
Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial.
Laterre PF, Pickkers P, Marx G, Wittebole X, Meziani F, Dugernier T, Huberlant V, Schuerholz T, François B, Lascarrou JB, Beishuizen A, Oueslati H, Contou D, Hoiting O, Lacherade JC, Chousterman B, Pottecher J, Bauer M, Godet T, Karakas M, Helms J, Bergmann A, Zimmermann J, Richter K, Hartmann O, Pars M, Mebazaa A; AdrenOSS-2 study participants. Laterre PF, et al. Intensive Care Med. 2021 Nov;47(11):1284-1294. doi: 10.1007/s00134-021-06537-5. Epub 2021 Oct 4. Intensive Care Med. 2021. PMID: 34605947 Free PMC article. Clinical Trial.